Welcome to our dedicated page for CARECLOUD news (Ticker: CCLDO), a resource for investors and traders seeking the latest updates and insights on CARECLOUD stock.
News for CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (Nasdaq: CCLDO) is closely tied to the operating and capital markets activities of CareCloud, Inc., a healthcare technology and AI-focused company. Investors following CCLDO typically monitor company announcements about preferred stock dividends, redemption terms, financial performance, acquisitions, and AI product launches, since these developments provide context for the preferred security.
CareCloud regularly issues press releases detailing its preferred stock dividend policies and payments. For the Series B Preferred Stock, the company has announced monthly cash dividends, described the cumulative nature of those dividends, and outlined record and payment dates. It has also communicated plans to address accumulated dividend arrears on the Series B Preferred Stock through double monthly dividend payments that combine regular dividends with catch-up payments until past due amounts are fully satisfied.
Beyond dividend-specific updates, the news flow includes information about CareCloud’s broader business performance and strategy. The company has reported quarterly financial results, discussed revenue guidance, and highlighted periods of positive GAAP net income and adjusted EBITDA. It has also described acquisitions such as Medsphere’s hospital IT business and HFMA’s MAP App, which expand its presence in hospital and integrated health system markets and support its AI-driven revenue cycle and benchmarking capabilities.
CareCloud’s news also covers AI product introductions and enhancements, including the launch of stratusAI Desk Agent, an AI phone receptionist for patient access, and the integration of stratusAI Voice Audit for conversational intelligence and call analytics. Additional announcements describe the deployment of the Wellsoft emergency department information system in urgent care settings and the company’s AI Center of Excellence, which supports innovation across inpatient and ambulatory EHR, RCM, analytics, and patient engagement.
Investors and observers who track CCLDO can use this news stream to see how CareCloud’s dividend practices, redemption options, AI initiatives, acquisitions, and financial performance evolve over time. These updates provide insight into both the preferred stock’s income characteristics and the underlying healthcare technology platform that supports the issuer.
CareCloud (Nasdaq: CCLD), a provider of AI-powered healthcare technology and revenue cycle management solutions, has scheduled its Q2 2025 earnings release for August 5, 2025, before market opening.
The company will host a conference call for investors at 8:30 a.m. Eastern Time on the same day. Investors can access the live webcast and presentation slides at ir.carecloud.com/events, or join via audio-only option by dialing 201-389-0920.
CareCloud (Nasdaq: CCLD), a healthcare technology and revenue cycle management solutions provider, reported a remarkable 70% stock price increase in Q2 2025, emerging as one of the top gainers in the Russell Microcap® Index. The company was officially added to the index on June 30, 2025.
Key developments include the launch of an AI Center of Excellence, resumed M&A activities, conversion of 3.5 million Series A Preferred shares into Common Stock, and a healthy cash position of over $10 million. The company's strategic focus on AI innovation and intelligent health solutions positions it for continued growth in 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has been added to the Russell Microcap® Index effective June 30, 2025. The company experienced significant growth with its stock price rising approximately 70% during Q2 2025.
Notable achievements include launching an AI Center of Excellence, resuming acquisition activities, and maintaining a strong cash position of $10 million at Q2 end. Additionally, approximately 3.5 million shares of Series A Preferred Stock were converted to Common Stock on March 6, 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has announced reaching a significant milestone with a public float of $85.1 million as of June 30, 2025. This achievement triggers new SEC compliance requirements, specifically the need for auditor attestation of Internal Control over Financial Reporting (ICFR) under Sarbanes-Oxley Act Section 404(b).
The Company's current audit firm has indicated it lacks capacity to perform the required ICFR attestation. As SEC regulations mandate the same firm conduct both financial statement audit and ICFR attestation, CareCloud has initiated a search for a new audit firm to handle these responsibilities for fiscal year 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, announced that its current independent registered public accounting firm may resign if the company requires an Internal Control over Financial Reporting (ICFR) attestation for fiscal year 2025.
The requirement for ICFR attestation will be determined by CareCloud's public float as of June 30, 2025. If it reaches or exceeds $75 million, the company will be classified as an accelerated filer, necessitating the attestation under Section 404(b) of the Sarbanes-Oxley Act. The current audit firm has stated it lacks capacity for ICFR attestation, which would require CareCloud to engage a new accounting firm as SEC rules mandate the same firm conduct both financial statement audit and ICFR attestation.
CareCloud (NASDAQ: CCLD) held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders approved three key proposals. The meeting resulted in the re-election of three board members - Anne Busquet, Bill Korn, and Lawrence Sharnak - for two-year terms. Shareholders also approved the compensation package for named executive officers and the appointment of Rosenberg Rich Baker Berman, P.A. as the company's independent registered public accounting firm for the fiscal year 2025.
The re-elected board members bring significant experience: Busquet has over 30 years of executive experience with American Express and Interactive Corp, Korn previously served as CareCloud's CFO for 10 years until October 2023, and Sharnak held various senior leadership roles during his 30-year tenure at American Express.
CareCloud (NASDAQ: CCLD) has been named the "Top Healthcare IT Pick for 2025" by Maxim Group, highlighting the company's AI strategy and strong financial performance. Maxim Group's analyst Allen Klee emphasized CareCloud's attractive valuation, noting it trades at a 2026 EV/EBITDA multiple of 5.0x, significantly below the peer group average of 12.5x.
The company reported impressive Q1 2025 results with 52% year-over-year adjusted EBITDA growth. CareCloud's recently launched AI Center of Excellence, starting with 50 AI professionals and planning to expand to 500 by year-end, demonstrates its commitment to AI integration. The company's AI suite includes tools like cirrusAI Notes, cirrusAI Appeals, and cirrusAI Voice, positioning CareCloud as a leader in healthcare AI solutions.
CareCloud (CCLD) has announced monthly cash dividend payments for its Series A and Series B Preferred Stock for May and June 2025. Both series carry an 8.75% annual dividend rate on a $25.00 per share liquidation preference. The monthly dividend for both series is set at $0.18229 per share. Series A holders will receive an additional payment of $0.04688 per share, reflecting a 2.25% adjustment from a previous 11% dividend rate. The dividends will be paid on June 16, 2025, and July 15, 2025, with respective record dates of May 31 and June 30, 2025.